Amarin Corp Plc (AMRN)

[jomama9231]

After diving deeper. It seems the examiner brought up 3 articles regarding apo B but didn’t cite this specific one Kurabayashi. It’s a totally worthless article scientifically but the fact that the Judge didn’t see it as worthless is unfortunate. It also sucks it wasn’t cited bc that could have helped us.

What’s your opinion on us removing our NDA for the marine label and us prescribing Vascepa based on reduce it label and off label for marine label. We don’t need the marine label anymore. Would that interfere with generics? Can we do something like that if we get desperate?